Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis

Vox Sanguinis

Volumn 95, Issue 1, 2008, Pages 20-25

  Zimmermann, R ^a   Reske, S ^a   Metzler, P ^a   Schlegel, A ^a   Ringwald, J ^a   Eckstein, R ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Apheresis; Growth factors; Platelet; Platelet gel; Platelet rich plasma

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BLOOD DONOR; CELL AGGREGATION; CONTROLLED STUDY; HUMAN; LEUKOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTOPHERESIS;

BLOOD CELL COUNT; BLOOD PLATELETS; HUMANS; LEUKOCYTES; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET-DERIVED GROWTH FACTOR; PLATELETPHERESIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 44849128532     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2008.01062.x     Document Type: Article

References (45)

1. Savage B, Ruggeri ZM:Platelet thrombus formation in flowing blood in Michelson AD (ed.):Platelets, 2nd edn. San Diego, CA, Elsevier/Academic Press, 2007:359 376
2. Bouchard BA, Butenas S, Mann KG, Tracy PB:Interactions between platelets and the coagulation system in Michelson AD (ed.):Platelets, 2nd edn. San Diego, CA, Elsevier/Academic Press, 2007:377 402
3. Balasubramanian V, Grabowski E, Bini A, Nemerson Y:Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 2002 100:2787 2792
4. Rendu F, Brohard-Bohn B:The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001 12:261 273
5. Zimmermann R, Jakubietz R, Jakubietz M, Strasser E, Schlegel A, Wiltfang J, Eckstein R:Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 2001 41:1217 1224
6. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT:Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004 91:4 15
7. Bowen-Pope DF, Ross R, Seifert RA:Locally acting growth factors for vascular smooth muscle cells: endogenous synthesis and release from platelets. Circulation 1985 72:735 740
8. Greenhalgh DG:The role of growth factors in wound healing. J Trauma 1996 41:159 167
9. Pietrzak WS, Eppley BL:Platelet rich plasma: biology and new technology. J Craniofac Surg 2005 16:1043 1054
10. Christenson JT, Kalangos A:Autologous fibrin glue reinforced by platelets in surgery of ascending aorta. Thorac Cardiovasc Surg 2004 52:225 229
11. Burkus JK:Surgical treatment of the painful motion segment: matching technology with indications. Spine 2005 30:S7 S15
12. Anitua E, Sanchez M, Orive G, Andia I:The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007 28:4551 4560
13. Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S, Libener R, Cattana E, Levis A, Betta PG, Borzini P:The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion 2004 44:1013 1018
14. Rock G, Neurath D, Lu M, Alharbi A, Freedman M:The contribution of platelets in the production of cryoprecipitates for use in a fibrin glue. Vox Sang 2006 91:252 255
15. Christgau M, Moder D, Wagner J, Glassl M, Hiller KA, Wenzel A, Schmalz G:Influence of autologous platelet concentrate on healing in intra-bony defects following guided tissue regeneration therapy: a randomized prospective clinical split-mouth study. J Clin Periodontol 2006 33:908 921
16. Dugrillon A, Eichler H, Kern S, Klueter H:Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg 2002 31:615 619
17. Giannobile WV:Periodontal tissue engineering by growth factors. Bone 1996 19:23S 37S
18. Landesberg R, Roy M, Glickman RS:Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg 2000 58:297 300
19. Marx RE:Platelet-rich plasma: a source of multiple autologous growth-factors for bone grafts in Lynch SE, Genco RJ, Marx RE (eds):Tissue Engineering. Applications in Maxillofacial Surgery and Periodontics. Chicago, IL, Quintessence Publishing, 1999:71 82
20. Schliephake H:Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002 31:469 484
21. Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE:Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone 2004 34:665 671
22. Whitman DH, Berry RL, Green DM:Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997 55:1294 1299
23. Cancedda R, Giannoni P, Mastrogiacomo M:A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 2007 28:4240 4250
24. Sarkar MR, Augat P, Shefelbine SJ, Schorlemmer S, Huber-Lang M, Claes L, Kinzl L, Ignatius A:Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. Biomaterials 2006 27:1817 1823
25. Marx RE:Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004 62:489 496
26. Borzini P, Mazzucco L:Tissue regeneration and in loco administration of platelet derivatives: clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms. Transfusion 2005 45:1759 1767
27. Schlegel KA, Donath K, Rupprecht S, Falk S, Zimmermann R, Felszeghy E, Wiltfang J:De novo bone formation using bovine collagen and platelet-rich plasma. Biomaterials 2004 25:5387 5393
28. Schlegel KA, Zimmermann R, Thorwarth M, Neukam FW, Klongnoi B, Nkenke E, Felszeghy E:Sinus floor elevation using autogenous bone or bone substitute combined with platelet-rich plasma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 104:e15 e25
29. Thorwarth M, Rupprecht S, Falk S, Felszeghy E, Wiltfang J, Schlegel KA:Expression of bone matrix proteins during de novo bone formation using a bovine collagen and platelet-rich plasma (PRP) - an immunohistochemical analysis. Biomaterials 2005 26:2575 2584
30. Wiltfang J, Kloss FR, Kessler P, Nkenke E, Schultze-Mosgau S, Zimmermann R, Schlegel KA:Effects of platelet-rich plasma on bone healing in combination with bone substitutes in critical-size defects - an animal experiment. Clin Oral Implants Res 2004 15:187 193
31. Zimmermann R, Arnold D, Strasser E, Ringwald J, Schlegel A, Wiltfang J, Eckstein R:Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang 2003 85:283 289
32. Everts PA, Brown Mahoney C, Hoffmann JJ, Schonberger JP, Box HA, van Zundert A, Knape JT:Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release. Growth Factors 2006 24:165 171
33. Everts PA, Hoffmann J, Weibrich G, Mahoney CB, Schonberger JP, van Zundert A, Knape JT:Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus Med 2006 16:363 368
34. Everts PA, Jakimowicz JJ, van Beek M, Schonberger JP, Devilee RJ, Overdevest EP, Knape JT, van Zundert A:Reviewing the structural features of autologous platelet-leukocyte gel and suggestions for use in surgery. Eur Surg Res 2007 39:199 207
35. Council of Europe Committee of Ministers:Guide to the Use, Preparation and Quality Control of Blood Components. Recommendation no. R (95) 15, 12th edn. Strasbourg, Council of Europe Publishing, 2006
36. German Medical Association Paul Ehrlich Institute:Guidelines for the Collection of Blood and Blood Components and the Use of Blood Products (Hemotherapy). Cologne, Germany, Deutscher Aerzteverlag, 2005
37. Ringwald J, Duerler T, Frankow O, Zimmermann R, Zingsem J, Strasser E, Antoon M, Eckstein R:Collection of hyperconcentrated platelets with Trima Accel. Vox Sang 2006 90:92 96
38. Lutz P, Dzik WH:Large-volume hemocytometer chamber for accurate counting of white cells (WBCs) in WBC-reduced platelets: validation and application for quality control of WBC-reduced platelets prepared by apheresis and filtration. Transfusion 1993 33:409 412
39. Snyder EL, Calhoun BC:Topical platelet growth factor therapy: of lotions and potions. Transfusion 2001 41:1186 1189
40. Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M:The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 2006 17:212 219
41. Haschberger B, Waterkamp A, Heiden M, Seitz R:Report on Notifications pursuant to Section 21 German Transfusion Act for 2001 and 2002 [German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2005 48:99 119
42. Sullivan MT, Cotten R, Read EJ, Wallace EL:Blood collection and transfusion in the United States in 2001. Transfusion 2007 47:385 394
43. Waxman DA:Volunteer donor apheresis. Ther Apher 2002 6:77 81
44. Reik RA, Noto TA, Fernandez HF:Safety of large-volume leukapheresis for collection of peripheral blood progenitor cells. J Clin Apheresis 1997 12:10 13
45. Ringwald J, Zimmermann R, Eckstein R:The new generation of platelet additive solution for storage at 22°C: development and current experience. Transfus Med Rev 2006 20:158 164